Casi PharmaceuticalsCASIF
13F holders, Q4 2024 (December 31)22holders +2
2new positions
2sold out
1famous investor
$2.83avg. 13F price*
At the end of Q4 2024, 22 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were Foresite Capital Management VI LLC ($3.8M), Venrock Adviser, LLC ($2.8M) and Woodline Partners LP ($282K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $394 |
| Exits | 2 | $135K |
All 13F filers, Q3 2024 → Q4 2024: 69,347 shares bought and 63,093 shares sold, net +6,254 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Foresite Capital Management VI LLC | 1.68% | — | 1,329,383 | $3.8M |
| Venrock Adviser, LLC | 0.19% | No change | 987,259 | $2.8M |
| Woodline Partners LP | 0.00% | Add +226.5% | 99,690 | $282K |
| Wellington Shields Capital Management, LLC | 0.04% | Reduce -3.8% | 85,835 | $243K |
| ADAR1 Capital Management, LLC | 0.03% | Reduce -28.6% | 46,320 | $131K |
| Renaissance Technologies | 0.00% | Reduce -5.1% | 39,400 | $112K |
| Wellington Shields & Co., LLC | 0.03% | Reduce -30.2% | 30,091 | $85K |
| Geode Capital Management, LLC | 0.00% | No change | 19,363 | $55K |
| UBS Group AG | 0.00% | Reduce -23.0% | 11,308 | $32K |
| Royal Bank of Canada | 0.00% | No change | 6,900 | $20K |
| Morgan Stanley | 0.00% | Add +3.5% | 1,490 | $4K |
| Wells Fargo & Company | 0.00% | Reduce -0.2% | 505 | $1K |
| BlackRock, Inc. | 0.00% | No change | 296 | $838 |
| BNP Paribas Financial Markets | 0.00% | New | 134 | $379 |
| West Paces Advisors Inc. | 0.00% | No change | 100 | $283 |
| Bank of America Corp. | 0.00% | No change | 28 | $79 |
| JPMorgan Chase & Co. | 0.00% | No change | 25 | $71 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 13 | $37 |
| Colonial Trust Co / SC | 0.00% | No change | 11 | $31 |
| Trust Co. of Vermont | 0.00% | No change | 10 | $28 |
| MAI Capital Management | 0.00% | New | 5 | $15 |
| Wingate Wealth Advisors, Inc. | 0.00% | — | 2 | $6 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.